PATENT CLAIM ANALYSIS

Application Number: 16111700
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "256000"]

Abstract:
The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.

Claim (Index 4):
The method of  claim 2 , wherein R 5  is phenyl which is para-substituted with a substituent of the form R 8 -R 9 -(R 10 ) a (R 10 ) b .

Metadata:
- Claim Count in Document: 113.0
- Percentile: 96.0
- Lexical Diversity: 1.15625
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15680842', '14938544', '14349688', '10578594', '12275165']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7854570277875911
- 35 USC 102 Novelty (BERT): 0.5704552213789461
- Combined Prediction Score: 0.7639568471467266
- Mean Citation Score: 375.501834
- Max Citation Score: 434.56226
- Similarity Product: 406.5313476961684

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test